Filtered By:
Management: Funding
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 633 results found since Jan 2013.
Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study
Lancet Neurol. 2023 Apr;22(4):320-329. doi: 10.1016/S1474-4422(23)00067-4.ABSTRACTBACKGROUND: The prevalence of atherosclerosis and the long-term risk of major vascular events in people who have had a transient ischaemic attack or minor ischaemic stroke, regardless of the causal relationship between the index event and atherosclerosis, are not well known. In this analysis, we applied the ASCOD (atherosclerosis, small vessel disease, cardiac pathology, other causes, and dissection) grading system to estimate the 5-year risk of major vascular events according to whether there was a causal relationship between atherosclerosis...
Source: Atherosclerosis - March 17, 2023 Category: Cardiology Authors: Philippa C Lavall ée Hugo Charles Gregory W Albers Louis R Caplan Geoffrey A Donnan Jos é M Ferro Michael G Hennerici Julien Labreuche Carlos Molina Peter M Rothwell Philippe Gabriel Steg Pierre-Jean Touboul Shinichiro Uchiyama Éric Vicaut Lawrence K S Source Type: research
MRI for all: Cheap portable scanners aim to revolutionize medical imaging
.news-article__hero--featured .parallax__element{ object-position: 47% 50%; -o-object-position: 47% 50%; }
The patient, a man in his 70s with a shock of silver hair, lies in the neuro intensive care unit (neuro ICU) at Yale New Haven Hospital. Looking at him, you’d never know that a few days earlier a tumor was removed from his pituitary gland. The operation didn’t leave a mark because, as is standard, surgeons reached the tumor through his nose. He chats cheerfully with a pair of research associates who have come to check his progress with a new and potentially revolutionary device they are testing.
The cylind...
Source: Science of Aging Knowledge Environment - February 23, 2023 Category: Geriatrics Source Type: research
Blackford and Brainomix partner on AI for stroke care
Artificial intelligence (AI) software developers Blackford and Brainomix hav...Read more on AuntMinnie.comRelated Reading:
Bayer buys Scottish radiology AI firm Blackford Analysis
Blackford inks partnership with Bialogics
Brainomix, Bridge Biotherapeutics partner
Blackford, Us2.ai partnering on echo technology
Funding for imaging AI companies tops $1.2B
Source: AuntMinnie.com Headlines - January 25, 2023 Category: Radiology Source Type: news
Corrigendum to ‘Self-Reported Race as a Social Determinant of Stroke Risk in Observational Versus Clinical Trial Datasets’
The authors regret omitting the funding support for Dr. Karen C. Johnston's effort on the project, National Center for Advancing Translational Science of the National Institutes of Health Award UL1TR003015/ KL2TR003016. The authors would like to apologize for any inconvenience caused.
Source: Journal of Stroke and Cerebrovascular Diseases - December 19, 2022 Category: Neurology Authors: Alison L. Herman, Kevin N. Sheth, Olajide A. Williams, Karen C. Johnston, Shyam Prabhakaran, Adamde Havenon Tags: Corrigendum Source Type: research
The final puff: Can New Zealand quit smoking for good?
Smoking kills. Ayesha Verrall has seen it up close. As a young resident physician in New Zealand’s public hospitals in the 2000s, Verrall watched smokers come into the emergency ward every night, struggling to breathe with their damaged lungs. Later, as an infectious disease specialist, she saw how smoking exacerbated illness in individuals diagnosed with tuberculosis and HIV/AIDS. She would tell them: “The best thing you can do to promote your health, other than take the pills, is to quit smoking.”
Verrall is still urging citizens to give up cigarettes—no longer just one by one, but by the thousands. As New...
Source: ScienceNOW - December 9, 2022 Category: Science Source Type: news
Real-World Study Confirms Benefit of XARELTO ® (rivaroxaban) for Secondary Prevention of Venous Thromboembolism in Cancer Patients
TITUSVILLE, NJ, December 9, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced observational data from eight years of clinical practice showing that the oral Factor Xa inhibitor XARELTO® (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a broad cohort of patients with various cancer types. Patients with CAT are at a higher risk of venous thromboembolism (VTE), which is the second-leading cause of death in people with cancer.1Data from the Observational Study in Cancer-A...
Source: Johnson and Johnson - December 9, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
Chronic non-communicable diseases: Hainan prospective cohort study
Purpose
The Hainan Cohort was established to investigate the incidence, morbidity and mortality of non-communicable diseases and their risk factors in the community population.
Participants
The baseline investigation of the Hainan Cohort study was initiated in five main areas of Hainan, China, from June 2018 to October 2020. A multistage cluster random-sampling method was used to obtain samples from the general population. Baseline assessments included a questionnaire survey, physical examination, blood and urine sample collection, and laboratory measurements, and outdoor environmental data were obtained.
Findings to dat...
Source: BMJ Open - November 18, 2022 Category: General Medicine Authors: Gu, X., Lin, L., Zhao, C., Wu, L., Liu, Y., He, L., Lin, G., Lin, Y., Zhang, F. Tags: Open access, Public health Source Type: research
14 Saving Adam from the apple: using transcranial magnetic stimulation as a transdiagnostically relevant tool to decrease cue-reactivity
Professor Hanlon’s scientific research has been to map neural circuit irregularities in substance dependent populations and then modulate these circuits using brain stimulation techniques or neurofeedback. She is leading NIH-funded research directed at longitudinal investigations of neural connectivity in cocaine & alcohol dependent individuals undergoing substance abuse treatment, & developing patient-tailored brain stimulation protocols which may either enhance cognitive control or attenuate craving in treatment seeking individuals. Her trainees & collaborators are pioneering non-invasive neuromodulator...
Source: Journal of Neurology, Neurosurgery and Psychiatry - November 14, 2022 Category: Neurosurgery Authors: Hanlon, C. A. Tags: Speakers Short Biographies and Abstracts Source Type: research
How AI Is Changing Medical Imaging to Improve Patient Care
That doctors can peer into the human body without making a single incision once seemed like a miraculous concept. But medical imaging in radiology has come a long way, and the latest artificial intelligence (AI)-driven techniques are going much further: exploiting the massive computing abilities of AI and machine learning to mine body scans for differences that even the human eye can miss.
Imaging in medicine now involves sophisticated ways of analyzing every data point to distinguish disease from health and signal from noise. If the first few decades of radiology were about refining the resolution of the pictures taken of...
Source: TIME: Health - November 4, 2022 Category: Consumer Health News Authors: Alice Park and Video by Andrew D. Johnson Tags: Uncategorized Frontiers of Medicine 2022 healthscienceclimate Innovation sponsorshipblock Source Type: news
Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
Lancet Respir Med. 2022 Oct 10:S2213-2600(22)00298-3. doi: 10.1016/S2213-2600(22)00298-3. Online ahead of print.ABSTRACTBACKGROUND: COVID-19 disease is accompanied by a dysregulated immune response and hypercoagulability. The Anti-Coronavirus Therapies (ACT) inpatient trial aimed to evaluate anti-inflammatory therapy with colchicine and antithrombotic therapy with the combination of rivaroxaban and aspirin for prevention of disease progression in patients hospitalised with COVID-19.METHODS: The ACT inpatient, open-label, 2 × 2 factorial, randomised, controlled trial was done at 62 clinical centres in 11 countries. Patient...
Source: Respiratory Care - October 13, 2022 Category: Respiratory Medicine Authors: John W Eikelboom Sanjit S Jolly Emilie P Belley-Cote Richard P Whitlock Sumathy Rangarajan Lizhen Xu Laura Heenan Shrikant I Bangdiwala Maria Luz Diaz Rafael Diaz Afzalhussein Yusufali Sanjib Kumar Sharma Wadea M Tarhuni Mohamed Hassany Alvaro Avezum Will Source Type: research
Corrigendum to ‘Predictive value of the combination between the intracranial arterial culprit plaque characteristics and the Essen Stroke Risk Score for short-term stroke recurrence’ Journal of Stroke and Cerebrovascular Diseases Volume 31, Issue 9, September 2022, 106624
This study was funded by grants from the Nantong Municipal Science and Technology Plan Project (Nos. MS12020041, MS12021101, HS2019002) and Nantong Municipal Health Commission Youth Project (No. MB2020001).
Source: Journal of Stroke and Cerebrovascular Diseases - October 13, 2022 Category: Neurology Authors: Kaixuan Ren, Huayun Jiang, Tiantian Li, Chengqun Qian, Shenchu Gong, Tianle Wang, Li Zhu Tags: Corrigendum Source Type: research
We are preventing some dementias now-But how? The Potamkin lecture
Alzheimers Dement. 2022 Sep 22. doi: 10.1002/alz.12770. Online ahead of print.ABSTRACTMost dementias are untreatable and their prevalence is increasing around the world. However, the incidence of dementia is declining in some countries. We need to find out urgently why and how and apply the lessons promptly and widely. Given the multiplicity and variability of environmental, socioeconomic, and individual risk and protective factors, the approach needs to be comprehensive, customized to work in a particular setting, and cost effective, to justify the needed funding. Stroke, heart disease, and dementia share the same major p...
Source: The Journal of Alzheimers Association - September 22, 2022 Category: Psychiatry Authors: Vladimir Hachinski Dementia Prevention/Brain Health Initiative Source Type: research
AHA News: She Had a Stroke During a Video Call With Her Congressional Representative
TUESDAY, Sept. 13, 2022 (American Heart Association News) -- Getting ready for her annual meeting with members of Congress to seek more funding for Alzheimer ' s disease research, Ann Walters Tillery needed strong Wi-Fi for the video meeting.
She had...
Source: Drugs.com - Daily MedNews - September 13, 2022 Category: General Medicine Source Type: news
RapidPulse Raises Additional Funding for Ischemic Stroke Therapies and Notes Promising Results
MIAMI, Sept. 13, 2022 -- (Healthcare Sales & Marketing Network) -- RapidPulse, Inc., a privately-held medical device company developing a novel aspiration system to treat ischemic stroke, today announced that it has raised an additional $10.5 million, bri... Devices, Interventional, Neurology, Venture Capital RapidPulse, Cyclic Aspiration System, stroke
Source: HSMN NewsFeed - September 13, 2022 Category: Pharmaceuticals Source Type: news
